Online inquiry

IVTScrip™ mRNA-Human ARL2BP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28639MR)

This product GTTS-WK28639MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL2BP protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_012106.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23568
UniProt ID Q9Y2Y0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL2BP, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28639MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5377MR IVTScrip™ mRNA-Human CD63, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CD63
GTTS-WK12797MR IVTScrip™ mRNA-Human ADAM9, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAM9
GTTS-WK13108MR IVTScrip™ mRNA-Human ADAMTSL1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAMTSL1
GTTS-WK18136MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA alpha-Sarcoglycan
GTTS-WK19722MR IVTScrip™ mRNA-Human ANKRD36BP2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD36BP2
GTTS-WK22278MR IVTScrip™ mRNA-Human ARGFX, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARGFX
GTTS-WK11370MR IVTScrip™ mRNA-Human ADRBK2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADRBK2
GTTS-WK10705MR IVTScrip™ mRNA-Human ADAMTS6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW